Systemic immunity in cancer

KJ Hiam-Galvez, BM Allen, MH Spitzer - Nature reviews cancer, 2021 - nature.com
Immunotherapy has revolutionized cancer treatment, but efficacy remains limited in most
clinical settings. Cancer is a systemic disease that induces many functional and …

Monocyte programming by cancer therapy

M Patysheva, A Frolova, I Larionova… - Frontiers in …, 2022 - frontiersin.org
Monocytes in peripheral blood circulation are the precursor of essential cells that control
tumor progression, that include tumor-associated macrophages (TAMs), dendritic cells …

Ewing sarcoma and osteosarcoma have distinct immune signatures and intercellular communication networks

AR Cillo, E Mukherjee, NG Bailey, S Onkar… - Clinical Cancer …, 2022 - AACR
Purpose: Ewing sarcoma and osteosarcoma are primary bone sarcomas occurring most
commonly in adolescents. Metastatic and relapsed disease are associated with dismal …

Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung Cancer

P Rochigneux, A Lisberg, A Garcia, S Granjeaud… - Clinical Cancer …, 2022 - AACR
Purpose: Immune checkpoint inhibitors (ICI) have revolutionized the treatment of non–small
cell lung cancer (NSCLC), but predictive biomarkers of their efficacy are imperfect. The …

Effect of early-stage human breast carcinoma on monocyte programming

M Patysheva, I Larionova, M Stakheyeva… - Frontiers in …, 2022 - frontiersin.org
Circulating monocytes are a major source of tumor-associated macrophages (TAMs). TAMs
in human breast cancer (BC) support primary tumor growth and metastasis. Neoadjuvant …

Moxibustion for the Treatment of Cancer and its Complications: Efficacies and Mechanisms

S Lu, B Wang, J Wang, Y Guo, S Li… - Integrative Cancer …, 2023 - journals.sagepub.com
Cancer treatment remains a significant challenge for the medical community, and improved
therapies are necessary to treat cancer and its associated complications. Current anticancer …

Naples prognostic score: a novel predictor of survival in patients with HER2-positive breast cancer

Y Chen, Z Guan, G Shen - Future Oncology, 2022 - Taylor & Francis
Purpose: The predictive significance of the Naples prognostic score (NPS) in HER2-positive
breast cancer is unclear. Hence we sought to evaluate the relationship between NPS and …

[HTML][HTML] Tumor-derived cyclooxygenase-2 fuels hypothalamic inflammation

X Li, X Zhu, P Diba, X Shi, F Vrieling… - Brain, Behavior, and …, 2025 - Elsevier
Hypothalamic inflammation often coincides with cancer and cachexia-anorexia. Prior work
established the significance of tumor-derived inflammatory factors in triggering hypothalamic …

Atezolizumab plus chemotherapy vs. Chemotherapy in advanced or metastatic triple-negative breast cancer: A cost-effectiveness analysis

X Liu, Y Lang, Y Liao, Y Zhu - Frontiers in Public Health, 2021 - frontiersin.org
Purpose: The IMpassion130 trial demonstrated the efficacy of adding atezolizumab to
paclitaxel for advanced or metastatic triple-negative breast cancer (TNBC). The current study …

Monocyte subsets in breast cancer patients under treatment with aromatase inhibitor and mucin-1 cancer vaccine

V Knöbl, L Maier, S Grasl, C Kratzer, F Winkler… - Journal of Translational …, 2024 - Springer
Background Monocytes comprise subsets of classical, intermediate and non-classical
monocytes with distinct anti-or pro-tumor effects in breast cancer (BC). They are modulated …